Literature DB >> 542059

[Miniaturized methods to monitor intracranial pressure. Technical and clinical results (author's transl)].

M Gaab, O E Knoblich, K Dietrich.   

Abstract

The prognosis of numerous diseases of the central nervous system is essentially determined by the intracranial pressure (ICP) and its therapeutic influencing. Long-term monitoring of the ICP must therefore be the objective in neurological and neurosurgical patients at risk. For this purpose, miniaturized methods were tested and developed. To monitor the intracranial pressure in patients who were not operated on, a miniature pressure transducer the size of a match head was used which was directly implanted 'percutaneously' in the intensive care unit: After a stab wound had been made in the skin, a 5-mm burrhole is made; the specially constructed miniature coaxial burr which disengages as soon as it touches the dura automatically enables coplanar epidural implantation of the transducer by means of an adapter capsule. The skin is closed without tension. For monitoring the pressure after trepanation, a spiralled miniature pressure transducer is implanted. The equally flattened receiver with lateral membranes is placed intracranially as desired, e.g., epidurally or subdurally, durin the operation. The zero point can be checked from outside without danger of infection. After the end of the measurements the recorder is easily extracted. Up to the present time, the epidural pressure has been reliably monitored for several weeks by this method in 86 patients. Ten comparative measurements showed corresponding cerebrospinal fluid pressures to within a few mm Hg with very good reproduction of frequency and amplitude. Small zero drift and the external zero control give an accuracy of measurement +/- 5 mm Hg independently of the time of measurement. The measurement permits early recognition of progressive intracranial space-occupying lesions. In 14 patients (16%) a measured rise in intracranial pressure was an essential basis for indication for neurosurgical operations. In addition, the pressure measurement provides an objective assessment of the effect of measures to lower the ICP; progressive increases in intracranial pressure which cannot be influenced conservatively can be brought for surgical decompression in good time before the brain has been irreversibly damaged by pressure. In craniocerebral traumata, monitoring the intracranial pressure permits the differentiation of primary damage to the brain stem with uniform, normal intracranial pressure from secondary constrictions of the brain stem with considerable rise of intracranial pressure and disturbed autoregulation. Only in chronic subdural haematomata are considerable displacements of intracranial masses to be seen with only slightly increased ICP ( less than 30 mm Hg). Besides space-occupying lesions, the measurement of pressure also detects generalised epileptic attakcs due to a considerable rise in intracranial pressure caused by hyperemia. Also disorders of respiration are recognised by supervision of ICP. The procedures described seem suitable for routine monitoring of ICP in patients at risk, with little operative effort and minimum danger...

Entities:  

Mesh:

Year:  1979        PMID: 542059     DOI: 10.1007/BF01232091

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  14 in total

1.  Continuous recording and control of ventricular fluid pressure in neurosurgical practice.

Authors:  N LUNDBERG
Journal:  Acta Psychiatr Scand Suppl       Date:  1960

2.  Is needle puncture of the brain entirely harmless.

Authors:  A S DEKABAN
Journal:  Neurology       Date:  1958-07       Impact factor: 9.910

3.  Use of long-term intracranial pressure measurement to assess hydrocephalic patients prior to shunt surgery.

Authors:  L Symon; N W Dorsch
Journal:  J Neurosurg       Date:  1975-03       Impact factor: 5.115

4.  [Continuous intracranial manometry; physiopathologic and clinical significance of the method].

Authors:  J GUILLAUME; P JANNY
Journal:  Presse Med       Date:  1951-07-04       Impact factor: 1.228

5.  Experience with an intracranial pressure transducer readjustable in vivo. Technical note.

Authors:  W Gobiet; W J Bock; J Liesegang; W Grote
Journal:  J Neurosurg       Date:  1974-02       Impact factor: 5.115

6.  Continuous recording of the ventricular-fluid pressure in patients with severe acute traumatic brain injury. A preliminary report.

Authors:  N Lundberg; H Troupp; H Lorin
Journal:  J Neurosurg       Date:  1965-06       Impact factor: 5.115

7.  Monitoring of intracranial pressure in patients with severe head injury.

Authors:  W Goblet
Journal:  Neurochirurgia (Stuttg)       Date:  1977-03

8.  [Importance of intensive therapy in the treatment of purulent meningitis (author's transl)].

Authors:  H Kunst
Journal:  MMW Munch Med Wochenschr       Date:  1976-12-03

9.  Summary of First International Symposium on Intracranial Pressure, Hannover, Germany, July 27-29, 1972.

Authors:  T W Langfitt
Journal:  J Neurosurg       Date:  1973-05       Impact factor: 5.115

10.  Continuous intracranial pressure monitoring: review of techniques and presentation of method.

Authors:  C P McGraw
Journal:  Surg Neurol       Date:  1976-09
View more
  4 in total

1.  A practical technique for continuous monitoring of cerebral tissue pressure in neurosurgical patients. Preliminary results.

Authors:  J Piek; B Kosub; F Küch; W J Bock
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

2.  Increased ICP without ventriculomegaly. Diagnostic and therapeutic problems in a 1-year-old boy.

Authors:  A Brawanski; N Soerensen
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

Review 3.  Neurological intensive care in children.

Authors:  J Pfenninger
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

4.  Continuous monitoring of cerebral tissue pressure in neurosurgical practice--experiences with 100 patients.

Authors:  J Piek; W J Bock
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.